Alphamab Oncology Market Cap

Alphamab Oncology has a market cap or net worth of 10.31 billion as of April 29, 2026. Its market cap has increased by 29.02% in one year.

Market Cap

10.31B

Enterprise Value

8.94B

Revenue

630.11M

Ranking

n/a

PE Ratio

n/a

Stock Price

10.64

Market Cap Chart

Since December 12, 2019, Alphamab Oncology's market cap has decreased from 12.11B to 10.31B, a decrease of -14.90%. That is a compound annual growth rate of -2.50%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	10.59B	11.53%
Dec 31, 2025	9.49B	181.80%
Dec 31, 2024	3.37B	-47.42%
Dec 29, 2023	6.41B	-36.87%
Dec 30, 2022	10.15B	-20.36%
Dec 31, 2021	12.74B	-16.28%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
HBM Holdings	11.52B
Lepu Biopharma	10.05B
Everest Medicines	12.43B
Abbisko Cayman	9.43B
Shanghai Haohai Biological Technology	9.38B
CARsgen Therapeutics Holdings	13.02B
CStone Pharmaceuticals	15.76B
Guangzhou Innogen Pharmaceutical Group	7.27B

Market Cap Rankings